MedTrace Logo

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

NCT07189117 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-12-23

No results posted yet for this study

Summary

This study investigates how metabolism in cancer and immune cells shapes the bone marrow environment, influences therapy resistance, and affects outcomes in hematological malignancies.

Conditions

  • Hematologic Malignancy

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Petya Apostolova, Prof. Dr. · University Hospital of Basel

  • Johannes Tossounidis, MD · University Hospital of Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-29
Primary Completion
2035-12-31
Completion
2040-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07189117 on ClinicalTrials.gov